Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2011

View Archived Issues

Four-marker signature exhibits improved prognostic accuracy in prostate cancer progression

Azacitidine has dual mechanism of action in resistant cancer cells

PTC Therapeutics achieves first milestone in BMI-1 collaboration with Wellcome Trust

BioDelivery Sciences announces results of FDA meeting on BEMA-delivered buprenorphine/naloxone

Novel HCV NS3/NS4A inhibitors patented by Idenix

Novel IAP inhibitors for treatment of cancer designed at Takeda

Servier presents new anticancer dihydroindolone analogues

Infinity Pharma's IPI-926 enters phase II trial and receives FDA orphan status in chondrosarcoma

Noscira presents new inhibitors of beta-secretase 1 and Abeta production

Kissei claims new catechol O-methyltransferase inhibitors

French scientists present new CK II inhibitors

FDA clears Palatin Technologies' IND for phase IIa PL-3994 trial in asthma

Cempra Pharma provides pipeline update on solithromycin and Taksta

InterMune receives approval for Esbriet in Europe

Endo Pharma launches Fortesta testosterone gel in U.S.

Novel TGFR-2-based trap T22d35 reduces tumor growth in vivo

ACT Biotech files SPA with FDA for phase III telatinib trial

Lycera and Merck & Co. enter into autoimmune treatment collaboration

AGS-004 delays rebound of HIV during interruption of antiretroviral therapy

Phase III ORAL Sync trial of Pfizer's tofacitinib meets primary endpoints

FDA approves removal of boxed warning regarding liver injury from Letairis label

European Commission approves Firazyr self-administration label for HAE

Ziopharm grants exclusive license to Solasia for Zinapar in Asia

Vical and EMA reach agreement on endpoints for pivotal phase III trial of TransVax vaccine

MediciNova and Zhejiang Medicine form partnership for MN-221 in China

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...